뒤로
Venus Medtech (Hangzhou) Inc.(02500.HK) 가격
02500.HK 주가 차트
VENUS MEDTECH-B (02500.HK)
Venus Medtech (Hangzhou) Inc.
HK$2.79
-1.41%
$-0.04
장 종료: Feb 16, 12:00:00 HKT
아직 데이터 없음Earnings FAQ
02500.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Venus Medtech (Hangzhou) Inc. 02500.HK의 지난 분기 매출 실적은 어땠나요?
Venus Medtech (Hangzhou) Inc.의 매출 추정치는 얼마인가요?
Venus Medtech (Hangzhou) Inc.의 수익 품질 점수는 얼마인가요?
Venus Medtech (Hangzhou) Inc.는 언제 수익을 보고하나요?
Venus Medtech (Hangzhou) Inc.의 예상 수익은 얼마인가요?
Venus Medtech (Hangzhou) Inc.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$2.82
시가
$2.83
일일 범위
$2.75 - $2.91
52주 범위
$1.59 - $5.62
거래량
776.0K
평균 거래량
1.8M
EPS(TTM)
-1.66
배당수익률
--
시가총액
$1.2B
VENUS MEDTECH-B란 무엇인가요?
Venus Medtech (Hangzhou), Inc. provides transcatheter heart valve medical device. The company is headquartered in Hangzhou, Zhejiang and currently employs 605 full-time employees. The company went IPO on 2019-12-10. The firm mainly engages in minimally invasive medical devices and auxiliary instruments and equipment for the treatment of heart valve diseases. The firm provides interventional heart valve devices for valvular heart disease including aortic valve, pulmonic valve, mitral valve and tricuspid valve, a radio frequency ablation system for interventional treatment of HCM, a renal artery denervation ultrasound ablation system for interventional treatment of hypertension and other accessory consumables. The firm's main products include the VenusA-Valve System, VenusA-Plus System, VenusA-Pilot System, VenusP-Valve System, TMVR valve, TTVR valve, valvuloplasty balloons V8/TAV8 and TriGUARD3 Cerebral Embolic Protection Device. The firm mainly conducts its businesses in the domestic market and overseas markets.